The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say made insulin prices soar.

September 21, 2024 - On Friday, the Biden-⁠Harris Administration highlighted new actions to support women’s economic security ...

It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...

Mastercard (NYSE: MA) stock price has done well since going public in 2006 when it raised $2.4 billion. It has jumped by ...

The FTC is sounding the alarm on social media companies over how they utilize users' data and children's personal information ...

On Wednesday, September 18, 2024, the Dodge County Sheriff’s Office was notified of a phone scam where the caller attempted ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...

A Federal Trade Commission report claims that the amount of data social media companies collect on users amounts to 'vast ...